Mr. Speaker, some time ago, the nation of Quebec brought in a pharmacare program for a number of reasons, including the one just raised by my NDP colleague. There has been talk about shared jurisdictions, but consecutive federal governments have failed to take responsibility for their own jurisdiction, particularly in relation to the regulatory framework for drug prices. What is my colleague's suggestion for that?
In the House of Commons on March 12th, 2020. See this statement in context.